These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32647034)

  • 21. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
    Kuriyama A; Urushidani S
    Heart Fail Rev; 2019 Jan; 24(1):31-39. PubMed ID: 30054781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.
    Civera J; de la Espriella R; Heredia R; Miñana G; Santas E; Conesa A; Mollar A; Sastre C; Martínez A; Villaescusa A; Núñez J
    J Cardiovasc Transl Res; 2022 Jun; 15(3):644-652. PubMed ID: 34642870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of diuretic use in the intensive care unit.
    McCoy IE; Chertow GM; Chang TI
    PLoS One; 2019; 14(5):e0217911. PubMed ID: 31150512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
    J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure.
    Lahav M; Regev A; Ra'anani P; Theodor E
    Chest; 1992 Sep; 102(3):725-31. PubMed ID: 1516394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
    Chan JSK; Kot TKM; Ng M; Harky A
    J Card Fail; 2020 Sep; 26(9):786-793. PubMed ID: 31730917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with low-dose metolazone and furosemide: a "needleless" approach in managing refractory fluid overload in elderly renal failure patients under palliative care.
    Cheng HW; Sham MK; Chan KY; Li CW; Au HY; Yip T
    Int Urol Nephrol; 2014 Sep; 46(9):1809-13. PubMed ID: 24824145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
    Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(6):679-703. PubMed ID: 11456215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
    Murray MD; Deer MM; Ferguson JA; Dexter PR; Bennett SJ; Perkins SM; Smith FE; Lane KA; Adams LD; Tierney WM; Brater DC
    Am J Med; 2001 Nov; 111(7):513-20. PubMed ID: 11705426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.
    Nieves LC; Mehrtens GM; Pores N; Pickrell C; Tanis J; Satty T; Chuang M; Young TC; Merlin MA
    Prehosp Disaster Med; 2015 Feb; 30(1):38-45. PubMed ID: 25592809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous Furosemide in Patients With Refractory Heart Failure.
    Lozano Bahamonde A; Escolar Pérez V; Echebarria Chousa A; Azcona Lucio A; Alfambra Vicente S; Rodríguez Rodríguez B
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):500-502. PubMed ID: 30029975
    [No Abstract]   [Full Text] [Related]  

  • 40. Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
    Gao Y; Gao Y; Zhu R; Tan X
    Medicine (Baltimore); 2021 Jan; 100(3):e24113. PubMed ID: 33546020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.